LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naive RET-mutant medullary thyroid cancer (MTC) Meeting Abstract


Authors: Hernando, J.; Tarasova, V.; Hu, M. I.; Sherman, E. J.; Brose, M. S.; Robinson, B.; Tahara, M.; Wirth, L. J.; Sashegyi, A.; Soldatenkova, V.; Lin, B. K.; Wright, J.; Hoff, A. O.; Leboulleux, S.; Elisei, R.; Capdevila, J.
Abstract Title: LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naive RET-mutant medullary thyroid cancer (MTC)
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S1091
Language: English
ACCESSION: WOS:000573469102511
DOI: 10.1016/j.annonc.2020.08.1415
PROVIDER: wos
Notes: Meeting Abstract: 1927TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric J Sherman
    344 Sherman